Titlebook: Wilson’s Disease; A Clinician’s Guide George J. Brewer Book 2001 Kluwer Academic Publishers 2001 Parkinson.biology.cognition.gastroenterol

Inveigle

書目名稱Wilson’s Disease影響因子(影響力)




書目名稱Wilson’s Disease影響因子(影響力)學科排名




書目名稱Wilson’s Disease網絡公開度




書目名稱Wilson’s Disease網絡公開度學科排名




書目名稱Wilson’s Disease被引頻次




書目名稱Wilson’s Disease被引頻次學科排名




書目名稱Wilson’s Disease年度引用




書目名稱Wilson’s Disease年度引用學科排名




書目名稱Wilson’s Disease讀者反饋




書目名稱Wilson’s Disease讀者反饋學科排名

RACE

ANIM

劇毒

,Overview of Management for the Clinician: What’s Important and What’s Not,n, we spent all of Chapter 4 reviewing in some detail the characteristics, uses, advantages and disadvantages of the anticopper drugs. These areas will be further elaborated on in Chapters 6–9 where treatment of specific kinds of patients is dealt with in detail. However, there are important general

包裹

Initial Treatment of Patients Who Present with Liver Disease,er (pp. 16–21), the liver disease presentation falls into three types: hepatic failure, hepatitis, and cirrhosis. Here, we will discuss the “initial treatment” of these types of patients. My working definition of initial treatment is that period of time when the patient is still undergoing, or is at

outset

Initial Treatment of Patients Who Present with Neurologic and/or Psychiatric Disease, but it was essentially a chelating substitute for penicillamine, to be used only in case of penicillamine toxicity. The medical mentality was very simple—you treated Wilson’s disease with penicillamine. There were no subtleties of using one kind of anticopper drug for one type of patient, and anoth

滔滔不絕地說

釋放

Therapy of the Presymptomatic, the Pediatric, and the Pregnant Patient,on, such as from working up the siblings of an affected patient, or an incidental observation of some abnormality (Chapter 2, pp. 24–25). That incidentally observed abnormality might be the presence of Kayser-Fleischer rings discovered by an ophthalmologist, or elevation of transaminase enzymes, or

矛盾

不透氣